ArticleJournal of Cancer2020

The Status of the EGFR T790M Mutation is associated with the Clinical Benefits of Osimertinib Treatment in Non-small Cell Lung Cancer Patients: A Meta-Analysis.

Zhe Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.